Position in LLY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,203,590,923
+$108,962,529 QoQ
Shares Held
1,003,469
-15.7% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#74
of 4,632 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $4,331,881,187 across 11 Drug Manufacturers - General names. LLY ranks #2 (27.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,891,125 | $1,242,199,016 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
1,003,469 | $1,203,590,923 | |
| 3 | ABBV |
AbbVie Inc.
|
2,578,333 | $648,811,716 | |
| 4 | AZN |
Astrazeneca PLC
|
1,621,109 | $307,394,688 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,334,726 | $300,012,291 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,971,583 | $249,089,796 | |
| 7 | AMGN |
Amgen Inc
|
420,259 | $152,184,189 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,007,448 | $115,669,153 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,203,590,923 | 1,003,469 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,094,628,394 | 1,190,111 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,272,616,829 | 1,184,182 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $691,722,066 | 906,582 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $945,905,087 | 1,213,430 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,076,281,311 | 1,303,146 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $970,972,964 | 1,257,737 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,207,881,736 | 1,363,390 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,303,522,664 | 1,439,752 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,151,067,281 | 1,479,597 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,139,656,981 | 1,955,083 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,037,372,596 | 1,931,325 | Shares | Defined | 2023-10-27 | |
| 2023-06-30 | $867,440,883 | 1,849,633 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $609,318,772 | 1,774,267 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $479,392,345 | 1,310,388 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $440,018,559 | 1,360,812 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $453,114,991 | 1,397,511 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $408,803,197 | 1,427,535 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $434,410,364 | 1,572,697 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $256,166,983 | 1,108,708 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $263,781,138 | 1,149,273 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $154,786,347 | 828,532 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $122,528,200 | 725,706 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $122,221,593 | 825,710 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $123,174,074 | 750,238 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $117,737,073 | 848,739 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||